{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:44:50Z","timestamp":1786171490345,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"DOI":"10.1007\/s10461-026-05251-x","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:21:51Z","timestamp":1786170111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence and Early Indicators of HBV and HCV Co-infection Among Newly Diagnosed HIV Patients: A Cross-Sectional Study from India"],"prefix":"10.1007","author":[{"given":"Nawaid Hussain","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Nandar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwajeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Narayan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Vashishtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit Kumar","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush Kumar","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5723-6346","authenticated-orcid":false,"given":"Chaitenya","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"8","key":"5251_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082388","volume":"15","author":"T Stroffolini","year":"2023","unstructured":"Stroffolini T, Stroffolini G. A historical overview on the role of hepatitis B and C viruses as aetiological factors for hepatocellular carcinoma. Cancers (Basel). 2023;15(8):2388. https:\/\/doi.org\/10.3390\/cancers15082388.","journal-title":"Cancers (Basel)"},{"key":"5251_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Global viral hepatitis. https:\/\/www.cdc.gov\/hepatitis\/global\/index.html. Accessed 25 July 2025."},{"issue":"1","key":"5251_CR3","first-page":"14","volume":"31","author":"MA Corcorran","year":"2023","unstructured":"Corcorran MA, Kim N. Chronic hepatitis B and HIV coinfection. Top Antivir Med. 2023;31(1):14\u201322.","journal-title":"Top Antivir Med"},{"issue":"15","key":"5251_CR4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","volume":"31","author":"KP Singh","year":"2017","unstructured":"Singh KP, Crane M, Audsley J, et al. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31(15):2035\u201352. https:\/\/doi.org\/10.1097\/QAD.0000000000001574.","journal-title":"AIDS"},{"key":"5251_CR5","doi-asserted-by":"publisher","first-page":"576715","DOI":"10.2147\/IDR.S576715","volume":"19","author":"R Bobadilla","year":"2026","unstructured":"Bobadilla R, MacLean F, Dave S, et al. Hepatic viral reservoirs in concurrent HIV and HBV: from mechanistic insight to integrated cure strategies. Infect Drug Resist. 2026;19:576715. https:\/\/doi.org\/10.2147\/IDR.S576715.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"5251_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrgastro.2014.17","volume":"11","author":"JY Chen","year":"2014","unstructured":"Chen JY, Feeney ER, Chung RT. HCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2014;11(6):362\u201371. https:\/\/doi.org\/10.1038\/nrgastro.2014.17.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"5251_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.14218\/JCTH.2016.00034","volume":"4","author":"JD Debes","year":"2016","unstructured":"Debes JD, Bohjanen PR, Boonstra A. Mechanisms of accelerated liver fibrosis progression during HIV infection. J Clin Transl Hepatol. 2016;4(4):328\u201335. https:\/\/doi.org\/10.14218\/JCTH.2016.00034.","journal-title":"J Clin Transl Hepatol"},{"key":"5251_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.853346","volume":"13","author":"SD Zaongo","year":"2022","unstructured":"Zaongo SD, Ouyang J, Chen Y, et al. HIV infection predisposes to increased chances of HBV infection: current understanding of the mechanisms favoring HBV infection at each clinical stage of HIV infection. Front Immunol. 2022;13:853346. https:\/\/doi.org\/10.3389\/fimmu.2022.853346.","journal-title":"Front Immunol"},{"issue":"5","key":"5251_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/v14050986","volume":"14","author":"GEM Rizzo","year":"2022","unstructured":"Rizzo GEM, Cabibbo G, Crax\u00ec A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses. 2022;14(5):986. https:\/\/doi.org\/10.3390\/v14050986.","journal-title":"Viruses"},{"key":"5251_CR10","doi-asserted-by":"publisher","first-page":"713981","DOI":"10.3389\/fmed.2021.713981","volume":"8","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Lin P, Cheng N. HBV\/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med (Lausanne). 2021;8:713981. https:\/\/doi.org\/10.3389\/fmed.2021.713981.","journal-title":"Front Med (Lausanne)"},{"key":"5251_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01086","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Bansal MB. Role of Kupffer cells in driving hepatic inflammation and fibrosis in HIV infection. Front Immunol. 2020;11:1086. https:\/\/doi.org\/10.3389\/fimmu.2020.01086.","journal-title":"Front Immunol"},{"issue":"4","key":"5251_CR12","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1074\/jbc.M110.168286","volume":"286","author":"W Lin","year":"2011","unstructured":"Lin W, Wu G, Li S, et al. HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB. J Biol Chem. 2011;286(4):2665\u201374. https:\/\/doi.org\/10.1074\/jbc.M110.168286.","journal-title":"J Biol Chem"},{"issue":"11","key":"5251_CR13","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/cid\/ciz1170","volume":"71","author":"S Leumi","year":"2020","unstructured":"Leumi S, Bigna JJ, Amougou MA, et al. Global burden of hepatitis B infection in people living with human immunodeficiency virus: a systematic review and meta-analysis. Clin Infect Dis. 2020;71(11):2799\u2013806. https:\/\/doi.org\/10.1093\/cid\/ciz1170.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"5251_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243534","volume":"15","author":"S Patil","year":"2020","unstructured":"Patil S, Rao A, Pathak P, et al. Unsterile injection equipment associated with HIV outbreak and an extremely high prevalence of HCV-A case-control investigation from Unnao, India. PLoS One. 2020;15(12):e0243534. https:\/\/doi.org\/10.1371\/journal.pone.0243534.","journal-title":"PLoS One"},{"issue":"7","key":"5251_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v16071","volume":"16","author":"T Stroffolini","year":"2024","unstructured":"Stroffolini T, Stroffolini G. Prevalence and modes of transmission of Hepatitis C virus infection: a historical worldwide review. Viruses. 2024;16(7):1115. https:\/\/doi.org\/10.3390\/v16071.","journal-title":"Viruses"},{"key":"5251_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/2325958219849061","volume":"18","author":"NH Khan","year":"2019","unstructured":"Khan NH, Kohli M, Gupta K, et al. HIV drug resistance mutations in patients with HIV and HIV-TB coinfection after failure of first-line therapy: a prevalence study in a resource-limited setting. J Int Assoc Provid AIDS Care. 2019;18:2325958219849061. https:\/\/doi.org\/10.1177\/2325958219849061.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"2","key":"5251_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2013.06.028","volume":"345","author":"I Rusyn","year":"2014","unstructured":"Rusyn I, Lemon SM. Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? Cancer Lett. 2014;345(2):210\u20135. https:\/\/doi.org\/10.1016\/j.canlet.2013.06.028.","journal-title":"Cancer Lett"},{"key":"5251_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726419","volume":"12","author":"ST Gobran","year":"2021","unstructured":"Gobran ST, Ancuta P, Shoukry NH. A tale of two viruses: immunological insights into HCV\/HIV coinfection. Front Immunol. 2021;12:726419. https:\/\/doi.org\/10.3389\/fimmu.2021.726419.","journal-title":"Front Immunol"},{"issue":"7","key":"5251_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797\u2013808. https:\/\/doi.org\/10.1016\/S1473-3099(15)00485-5.","journal-title":"Lancet Infect Dis"},{"key":"5251_CR20","doi-asserted-by":"publisher","first-page":"100965","DOI":"10.1016\/j.lana.2024.100965","volume":"41","author":"PF Belaunzar\u00e1n-Zamudio","year":"2024","unstructured":"Belaunzar\u00e1n-Zamudio PF, Mosqueda-G\u00f3mez JL, Cano-Torres JO, et al. Prevalence of hepatitis C virus co-infection in adults living with HIV in Mexico: a cross-sectional, seroprevalence study in a nationally representative sample. Lancet Reg Health Am. 2024;41:100965. https:\/\/doi.org\/10.1016\/j.lana.2024.100965.","journal-title":"Lancet Reg Health Am"},{"key":"5251_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/23259582241292511","volume":"23","author":"E Odeghe","year":"2024","unstructured":"Odeghe E, Oyeleke G, Odofin M, et al. Hepatitis B and C virus co-infection and their association with liver disease in persons with HIV in Nigeria. J Int Assoc Provid AIDS Care. 2024;23:23259582241292511. https:\/\/doi.org\/10.1177\/23259582241292511.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"6","key":"5251_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07172","volume":"7","author":"TB Kwofie","year":"2021","unstructured":"Kwofie TB, Adigbli D, Osei-Yeboah J, et al. Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity. Heliyon. 2021;7(6):e07172. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07172.","journal-title":"Heliyon"},{"key":"5251_CR23","doi-asserted-by":"publisher","first-page":"5212533","DOI":"10.1155\/anem\/5212533","volume":"2025","author":"UM Forgor","year":"2025","unstructured":"Forgor UM, Billak GD, Anabire NG, et al. Viral Hepatitis B\/C Co-infection and its association with haematological and virological parameters in HIV patients in Northern Ghana. Anemia. 2025;2025:5212533. https:\/\/doi.org\/10.1155\/anem\/5212533.","journal-title":"Anemia"},{"key":"5251_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9241679","volume":"2018","author":"M Bhattarai","year":"2018","unstructured":"Bhattarai M, Baniya JB, Aryal N, et al. Epidemiological profile and risk factors for acquiring HBV and\/or HCV in HIV-infected population groups in Nepal. Biomed Res Int. 2018;2018:9241679. https:\/\/doi.org\/10.1155\/2018\/9241679.","journal-title":"Biomed Res Int"},{"issue":"42","key":"5251_CR25","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.3748\/wjg.v12.i42.6879","volume":"12","author":"S Gupta","year":"2006","unstructured":"Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol. 2006;12(42):6879\u201383. https:\/\/doi.org\/10.3748\/wjg.v12.i42.6879.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5251_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jmv.24988","volume":"90","author":"S Su","year":"2018","unstructured":"Su S, Fairley CK, Sasadeusz J, et al. HBV, HCV, and HBV\/HCV co-infection among HIV-positive patients in Hunan province, China: regimen selection, hepatotoxicity, and antiretroviral therapy outcome. J Med Virol. 2018;90(3):518\u201325. https:\/\/doi.org\/10.1002\/jmv.24988.","journal-title":"J Med Virol"},{"issue":"4","key":"5251_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215377","volume":"14","author":"R Boateng","year":"2019","unstructured":"Boateng R, Mutocheluh M, Dompreh A, et al. Sero-prevalence of hepatitis B and C viral co-infections among HIV-1 infected ART-na\u00efve individuals in Kumasi, Ghana. PLoS One. 2019;14(4):e0215377. https:\/\/doi.org\/10.1371\/journal.pone.0215377.","journal-title":"PLoS One"},{"key":"5251_CR28","unstructured":"World Health Organization. Hepatitis B. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 10 June 2026."},{"issue":"10","key":"5251_CR29","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.4103\/jfmpc.jfmpc_202_24","volume":"13","author":"RK Jain","year":"2024","unstructured":"Jain RK, Shrivastava R, Jain SK, et al. Seropositivity and coinfection of hepatitis B and hepatitis C viruses in Central India: a hospital-based study. J Fam Med Primary Care. 2024;13(10):4413\u20138. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_202_24.","journal-title":"J Fam Med Primary Care"},{"issue":"5","key":"5251_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijid.2005.09.005","volume":"10","author":"T Hussain","year":"2006","unstructured":"Hussain T, Kulshreshtha KK, Sinha S, et al. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India. Int J Infect Dis. 2006;10(5):358\u201363. https:\/\/doi.org\/10.1016\/j.ijid.2005.09.005.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"5251_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073613","volume":"8","author":"D Saha","year":"2013","unstructured":"Saha D, Pal A, Biswas A, et al. Characterization of treatment-naive HIV\/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India. PLoS One. 2013;8(8):e73613. https:\/\/doi.org\/10.1371\/journal.pone.0073613.","journal-title":"PLoS One"},{"issue":"5","key":"5251_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jvh.13929","volume":"31","author":"HS Iqbal","year":"2024","unstructured":"Iqbal HS, Gunaratne MP, Loeb TA, et al. High prevalence of hepatitis B virus among MSM living with HIV in India. J Viral Hepat. 2024;31(5):271\u20134. https:\/\/doi.org\/10.1111\/jvh.13929.","journal-title":"J Viral Hepat"},{"issue":"2","key":"5251_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.hivar.2012.03.002","volume":"11","author":"T Hussain","year":"2012","unstructured":"Hussain T, Sharma KS, Kulshreshtha KK, et al. HIV and other co-infections among drug users attending the Integrated Counselling & Testing Centre (ICTC) at Agra, India. HIV AIDS Rev. 2012;11(2):49\u201353.","journal-title":"HIV AIDS Rev"},{"key":"5251_CR34","unstructured":"WHO. Guidelines on Hepatitis B and C testing. Geneva: World Health Organization; 2017. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442272\/."},{"key":"5251_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eclinm.2018.10.006","volume":"4\u20135","author":"G McKee","year":"2018","unstructured":"McKee G, Butt ZA, Wong S, et al. Syndemic characterization of HCV, HBV, and HIV co-infections in a large population based cohort study. EClinicalMedicine. 2018;4\u20135:99\u2013108. https:\/\/doi.org\/10.1016\/j.eclinm.2018.10.006.","journal-title":"EClinicalMedicine"},{"issue":"Suppl 1","key":"5251_CR36","first-page":"S17","volume":"19","author":"A Javadi","year":"2014","unstructured":"Javadi A, Ataei B, Kassaian N, et al. Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers. J Res Med Sci. 2014;19(Suppl 1):S17\u201321.","journal-title":"J Res Med Sci"},{"issue":"3","key":"5251_CR37","doi-asserted-by":"publisher","first-page":"e0264791","DOI":"10.1371\/journal.pone.0264791","volume":"17","author":"LB Shrestha","year":"2022","unstructured":"Shrestha LB, Yadav GK, Pradhan S, et al. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: a cross-sectional study from tertiary care hospital of eastern Nepal. PLoS ONE. 2022;17(3):e0264791. https:\/\/doi.org\/10.1371\/journal.pone.0264791.","journal-title":"PLoS ONE"},{"issue":"2","key":"5251_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4314\/ajcem.v23i2.9","volume":"23","author":"M Erasmus","year":"2022","unstructured":"Erasmus M, Akani N, Akani N, et al. Comparative analysis of haematological parameters in HIV patients with co-infections of hepatitis B & C, and HIV-negative patients in Rivers State, Nigeria. Af J Clin Exp Micro. 2022;23(2):182\u20139. https:\/\/www.ajol.info\/index.php\/ajcem\/article\/view\/22510.","journal-title":"Af J Clin Exp Micro"},{"issue":"12","key":"5251_CR39","doi-asserted-by":"publisher","first-page":"e37576","DOI":"10.1097\/MD.0000000000037576","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU. Platelet index ratios in HIV: Emerging biomarkers for immune health and disease management. Med (Baltim). 2024;103(12):e37576. https:\/\/doi.org\/10.1097\/MD.0000000000037576.","journal-title":"Med (Baltim)"},{"key":"5251_CR40","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/ITT.S495295","volume":"13","author":"NH Khan","year":"2024","unstructured":"Khan NH, Verma C, Beg MMA, et al. Evolution of hematobiochemical profiles in newly diagnosed HIV patients and HIV-TB co-infected patients: correlation with immunological and virological status. Immunotargets Ther. 2024;13:691\u2013705. https:\/\/doi.org\/10.2147\/ITT.S495295.","journal-title":"Immunotargets Ther"},{"issue":"6","key":"5251_CR41","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/microorganisms12061213","volume":"12","author":"GN Lungu","year":"2024","unstructured":"Lungu GN, Diaconescu GI, Dumitrescu F, et al. FibroScan\u00ae versus biochemical scores: a study of liver fibrosis in HIV with HBV co-infection. Microorganisms. 2024;12(6):1213. https:\/\/doi.org\/10.3390\/microorganisms12061213.","journal-title":"Microorganisms"},{"issue":"1","key":"5251_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41575-018-0085-7","volume":"16","author":"N Chamroonkul","year":"2019","unstructured":"Chamroonkul N, Bansal MB. HIV and the liver. Nat Rev Gastroenterol Hepatol. 2019;16(1):1\u20132. https:\/\/doi.org\/10.1038\/s41575-018-0085-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5251_CR43","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.2147\/IDR.S215974","volume":"12","author":"HA Osman","year":"2019","unstructured":"Osman HA, Ghweil AA, Sabry AM, et al. Management of patients with hepatitis B virus reactivation post-DAA treatment of chronic hepatitis C virus infection in HCV-HBV coinfected patients with pretreatment HBeAg seroconversion and early degree of hepatic fibrosis. Infect Drug Resist. 2019;12:3067\u201373. https:\/\/doi.org\/10.2147\/IDR.S215974.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"5251_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3748\/wjg.v25.i4.398","volume":"25","author":"M Ganesan","year":"2019","unstructured":"Ganesan M, Poluektova LY, Kharbanda KK, et al. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression. World J Gastroenterol. 2019;25(4):398\u2013410. https:\/\/doi.org\/10.3748\/wjg.v25.i4.398.","journal-title":"World J Gastroenterol"},{"key":"5251_CR45","doi-asserted-by":"publisher","first-page":"888050","DOI":"10.3389\/fmed.2022.888050","volume":"9","author":"DG Iacob","year":"2022","unstructured":"Iacob DG, Luminos M, Benea OE, et al. Liver fibrosis progression in a cohort of young HIV and HIV\/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores. Front Med (Lausanne). 2022;9:888050. https:\/\/doi.org\/10.3389\/fmed.2022.888050.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"5251_CR46","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.31823","volume":"74","author":"RK Sterling","year":"2021","unstructured":"Sterling RK, King WC, Khalili M, et al. A prospective study evaluating changes in histology, clinical and virologic outcomes in HBV-HIV co-infected adults in North America. Hepatology. 2021;74(3):1174\u201389. https:\/\/doi.org\/10.1002\/hep.31823.","journal-title":"Hepatology"},{"issue":"1","key":"5251_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jceh.2016.12.002","volume":"7","author":"P Puri","year":"2017","unstructured":"Puri P, Sharma PK, Lolusare A, et al. Liver function tests abnormalities and hepatitis B virus & hepatitis C virus co-infection in human immunodeficiency virus (HIV)-infected patients in India. J Clin Exp Hepatol. 2017;7(1):1\u20138. https:\/\/doi.org\/10.1016\/j.jceh.2016.12.002.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"5251_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4314\/gmj.v48i2.7","volume":"48","author":"HO Olawumi","year":"2014","unstructured":"Olawumi HO, Olanrewaju DO, Shittu AO, et al. Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients. Ghana Med J. 2014;48(2):96\u2013100. https:\/\/doi.org\/10.4314\/gmj.v48i2.7.","journal-title":"Ghana Med J"},{"issue":"11","key":"5251_CR49","doi-asserted-by":"publisher","first-page":"e73297","DOI":"10.7759\/cureus.73297","volume":"16","author":"DA Moran","year":"2024","unstructured":"Moran DA. Prevalence of opportunistic infections in treatment-naive HIV patients in a secondary care center. Cureus. 2024;16(11):e73297. https:\/\/doi.org\/10.7759\/cureus.73297. Published 2024 Nov 8.","journal-title":"Cureus"},{"issue":"4","key":"5251_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/QAI.0000000000000992","volume":"72","author":"HN Kim","year":"2016","unstructured":"Kim HN, Nance R, Van Rompaey S, et al. Poorly controlled HIV infection: an independent risk factor for liver fibrosis. J Acquir Immune Defic Syndr. 2016;72(4):437\u201343. https:\/\/doi.org\/10.1097\/QAI.0000000000000992.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5251_CR51","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2147\/HIV.S328362","volume":"13","author":"M Dembelu","year":"2021","unstructured":"Dembelu M, Woseneleh T. Prevalence of and factors associated with reoccurrence of opportunistic infections among adult HIV\/AIDS patients attending the ART clinic at public health facilities in Arba Minch Town, Southern Ethiopia. HIV AIDS (Auckl). 2021;13:867\u201376. https:\/\/doi.org\/10.2147\/HIV.S328362.","journal-title":"HIV AIDS (Auckl)"},{"issue":"3","key":"5251_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057331","volume":"8","author":"KH Lim","year":"2013","unstructured":"Lim KH, Choi HS, Park YK, et al. HBx-induced NF-\u03baB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO. PLoS One. 2013;8(3):e57331. https:\/\/doi.org\/10.1371\/journal.pone.0057331.","journal-title":"PLoS One"},{"issue":"17","key":"5251_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01057-20","volume":"94","author":"H Wang","year":"2020","unstructured":"Wang H, Liu Y, Huan C, et al. NF-\u03baB-interacting long noncoding RNA regulates HIV-1 replication and latency by repressing NF-\u03baB signaling. J Virol. 2020;94(17):e01057-20. https:\/\/doi.org\/10.1128\/JVI.01057-20.","journal-title":"J Virol"},{"issue":"1","key":"5251_CR54","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/j.ijid.2009.03.002","volume":"14","author":"A Rahimi-Movaghar","year":"2010","unstructured":"Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010;14(1):e28\u201333. https:\/\/doi.org\/10.1016\/j.ijid.2009.03.002.","journal-title":"Int J Infect Dis"},{"key":"5251_CR55","unstructured":"United Nations Office on Drugs and Crime. World drug report 2023. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html."},{"issue":"5","key":"5251_CR56","doi-asserted-by":"publisher","first-page":"e0302453","DOI":"10.1371\/journal.pone.0302453","volume":"19","author":"YM Hagos","year":"2024","unstructured":"Hagos YM, Yalew GT, Meles HN, et al. Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia. PLoS ONE. 2024;19(5):e0302453. https:\/\/doi.org\/10.1371\/journal.pone.0302453.","journal-title":"PLoS ONE"},{"issue":"1","key":"5251_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11489-2","volume":"7","author":"M Pokorska-\u015apiewak","year":"2017","unstructured":"Pokorska-\u015apiewak M, Sta\u0144ska-Perka A, Popielska J, et al. Prevalence and predictors of liver disease in HIV-infected children and adolescents. Sci Rep. 2017;7(1):12309. https:\/\/doi.org\/10.1038\/s41598-017-11489-2.","journal-title":"Sci Rep"},{"issue":"5","key":"5251_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050688","volume":"18","author":"RC Marin","year":"2025","unstructured":"Marin RC, Tit DM, Bung\u0103u G, et al. The impact of hepatitis B and\/or C on liver function and on the response to antiretroviral therapy in HIV-infected patients: a Romanian cohort study. Pharmaceuticals (Basel). 2025;18(5):688. https:\/\/doi.org\/10.3390\/ph18050688.","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05251-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:21:53Z","timestamp":1786170113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":58,"alternative-id":["5251"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05251-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"10 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Institutional ethical committee (IESC\/T-88\/01-02-2013), and written informed consent taken from all the study participants.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}